Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
Wenxue Ma, Editorial Board Member at Annals of Translational Medicine, External Expert Reviewer at Raine Medical Research Foundation, European Research Council (ERC) and NCN National Science Centre, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Drug Resistance Updates, adding:
“I would like to share a newly accepted review ‘Macrophage-centered resistance programs in cancer: A unified framework for therapeutic resistance and precision immunotherapy,’ published in Drug Resistance Updates.
We propose an integrative framework encompassing four interconnected macrophage-centered resistance programs: lipid-associated, matrix-remodeling, glyco-immune, and metabolic that contribute to immune evasion and therapeutic resistance.
This framework highlights potential strategies for overcoming treatment resistance through macrophage-directed interventions and biomarker-guided precision immunotherapy.”
Title: Macrophage-centered resistance programs in cancer: A unified framework for therapeutic resistance and precision immunotherapy
Authors: Yanjun Li, Suling Xu, Huangze Xie, Qingqing Wang, Lingeng Lu, Wenxue Ma
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice